Thursday, May 23, 2019 - 07:00

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces the results of the voting by shareholders at the Annual General Meeting (“AGM”) which took place on May 22, 2019, in Marseille, France. All resolutions were voted in accordance with the management team’s recommendations.

A total of 27,276,527 votes was cast out of a total of 64,039,842 shares with voting rights, representing a quorum of 42.593%.

Details of the votes are available on the Company’s website, in the Annual General Meeting 2019 section.



The 2018 Reference Document of the Company is available on its website